Fathi T. Halaweish
Affiliations: | South Dakota State University, Brookings, SD, United States |
Area:
Biochemistry, Molecular BiologyGoogle:
"Fathi Halaweish"Mean distance: (not calculated yet)
Children
Sign in to add traineeDaoning Zhang | grad student | 2004 | South Dakota State University |
Judit Bartalis | grad student | 2005 | South Dakota State University |
Eric Huntimer | grad student | 2005 | South Dakota State University |
Erin J. Mercer | grad student | 2010 | South Dakota State University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sikander M, Malik S, Khan S, et al. (2019) Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer). Cells. 9 |
Mahnashi M, Elgazwi SM, Ahmed MS, et al. (2019) Cucurbitacins inspired organic synthesis: Potential dual inhibitors targeting EGFR - MAPK pathway. European Journal of Medicinal Chemistry. 173: 294-304 |
Abou-Salim MA, Shaaban MA, Abd El Hameid MK, et al. (2019) Design, synthesis and biological study of hybrid drug candidates of nitric oxide releasing cucurbitacin-inspired estrone analogs for treatment of hepatocellular carcinoma. Bioorganic Chemistry. 85: 515-533 |
Sikander M, Malik S, Hafeez BB, et al. (2019) Abstract 4809: Bromo-ormeloxifene inhibits epithelial mesenchymal transitionviatargeting β-catenin signaling pathways in cervical cancer cells Cancer Research. 79: 4809-4809 |
Ismail RSM, Abou-Seri SM, Eldehna WM, et al. (2018) Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells. European Journal of Medicinal Chemistry. 155: 782-796 |
Gurusamy N, Alsayari A, Halaweish F. (2018) The role of cucurbitacins in combating cancers: A mechanistic review Pharmacognosy Reviews. 12: 157 |
Sikander M, Malik S, Hafeez BB, et al. (2018) Abstract 2934: Cucurbitacin D enhances the therapeutic efficacy of docetaxel via targeting cancer stem cells and miR-145 Cancer Research. 78: 2934-2934 |
Hafeez BB, Ganju A, Sikander M, et al. (2017) Ormeloxifene suppresses prostate tumor growth and metastatic phenotypes via inhibition of oncogenic β-catenin signaling and EMT progression. Molecular Cancer Therapeutics |
Elshaier YAMM, Shaaban MA, Abd El Hamid MK, et al. (2017) Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma. Bioorganic & Medicinal Chemistry. 25: 2956-2970 |
Ahmed MS, El-Senduny F, Taylor J, et al. (2017) Biological Screening of Cucurbitacin Inspired Estrone Analogs Targeting Mitogen Activated Protein Kinase (MAPK) Pathway. Chemical Biology & Drug Design |